IL90551A - Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions - Google Patents

Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions

Info

Publication number
IL90551A
IL90551A IL90551A IL9055189A IL90551A IL 90551 A IL90551 A IL 90551A IL 90551 A IL90551 A IL 90551A IL 9055189 A IL9055189 A IL 9055189A IL 90551 A IL90551 A IL 90551A
Authority
IL
Israel
Prior art keywords
injectable
stable
treatment
pharmaceutical compositions
aqueous pharmaceutical
Prior art date
Application number
IL90551A
Other languages
English (en)
Other versions
IL90551A0 (en
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of IL90551A0 publication Critical patent/IL90551A0/xx
Publication of IL90551A publication Critical patent/IL90551A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL90551A 1988-06-08 1989-06-07 Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions IL90551A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/203,836 US4857552A (en) 1988-06-08 1988-06-08 Stable pharmaceutical composition

Publications (2)

Publication Number Publication Date
IL90551A0 IL90551A0 (en) 1990-01-18
IL90551A true IL90551A (en) 1992-12-01

Family

ID=22755531

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90551A IL90551A (en) 1988-06-08 1989-06-07 Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions

Country Status (13)

Country Link
US (1) US4857552A (da)
EP (1) EP0403578B1 (da)
JP (1) JP2552372B2 (da)
AU (1) AU613196B2 (da)
CA (1) CA1334001C (da)
DE (1) DE68918847T2 (da)
DK (1) DK32490A (da)
HU (1) HUT54041A (da)
IL (1) IL90551A (da)
MY (1) MY104030A (da)
NZ (1) NZ229410A (da)
WO (1) WO1989011855A1 (da)
ZA (1) ZA894344B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405376A (en) * 1993-08-27 1995-04-11 Medtronic, Inc. Method and apparatus for ablation
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
WO1999007354A2 (en) * 1997-08-08 1999-02-18 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6310094B1 (en) * 2001-01-12 2001-10-30 Baxter International Inc. Ready-to-use esmolol solution
TWI277414B (en) * 2001-01-12 2007-04-01 Baxter Int Esmolol formulation
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
EP1417962A1 (de) 2002-11-06 2004-05-12 AOP Orphan Pharmaceuticals AG Verfahren zur Herstellung eines Arzneimittels enthaltend Esmolol
US20080293814A1 (en) 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
AU2014203121B2 (en) * 2007-05-22 2016-04-21 Baxter Healthcare Sa Concentrate esmolol
US20100311738A1 (en) 2007-12-21 2010-12-09 Aop Orphan Pharmaceuticals Ag Pharmaceutical Composition For The Parenteral Administration Of Ultrashort-Effective Beta-Adrenoreceptor Antagonists
CN102548538B (zh) * 2009-09-22 2014-03-12 V生命科学技术有限公司 治疗糖尿病足溃疡的局部制剂
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
EP2512236B1 (en) * 2009-12-18 2016-10-19 Metabolic Technologies, Inc. Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb)
JP2014505074A (ja) 2011-01-27 2014-02-27 バクスター・インターナショナル・インコーポレイテッド 血圧低下を最小化しおよび／または制御しながら頻脈を治療しおよび／または心拍数を制御する方法
BR112013018598A2 (pt) * 2011-01-27 2016-10-18 Baxter Healthcare Sa composição farmacêutica, método para tratar uma doença cardíaca, uso de (s)-metil-3-[4-(2-hidroxi-3-[4-(2-hidroxi-3-isopropilamino) propoxi] fenilpropionato, e, método para controlar frequência cardíaca
US8835505B1 (en) * 2013-03-15 2014-09-16 Welgrace Research Group Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
CN104473869A (zh) * 2014-11-20 2015-04-01 北京京科泰来科技有限公司 一种艾司洛尔脂肪乳及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
EP0179808B1 (en) * 1984-04-09 1991-10-30 The Du Pont Merck Pharmaceutical Company Pharmaceutical composition suitable for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
DE68918847D1 (de) 1994-11-17
US4857552A (en) 1989-08-15
WO1989011855A1 (en) 1989-12-14
AU3570489A (en) 1990-01-05
ZA894344B (en) 1991-02-27
CA1334001C (en) 1995-01-17
HU892994D0 (en) 1990-11-28
MY104030A (en) 1993-10-30
JP2552372B2 (ja) 1996-11-13
IL90551A0 (en) 1990-01-18
HUT54041A (en) 1991-01-28
EP0403578A4 (en) 1991-07-03
DK32490D0 (da) 1990-02-07
EP0403578A1 (en) 1990-12-27
AU613196B2 (en) 1991-07-25
JPH03500658A (ja) 1991-02-14
DK32490A (da) 1990-02-07
DE68918847T2 (de) 1995-03-16
NZ229410A (en) 1991-10-25
EP0403578B1 (en) 1994-10-12

Similar Documents

Publication Publication Date Title
IL90551A (en) Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
NO904694D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO875082D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NZ231508A (en) Hydroxamic acid derivatives, pharmaceutical compositions and intermediate compounds
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
IL85312A0 (en) Improving the stability of pharmaceutical compositions
NO893270L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
HUT45509A (en) Process for producing new aralkyl-imidazole derivatives and pharmaceutics comprising the same as active ingredient
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO900972L (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
HUT52072A (en) Microbicide compositions containing new halogeno-vinyl-azol derivatives as active components, and process for producing the active components
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
IL84012A0 (en) Pharmaceutical composition for the treatment of high blood pressure
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
NO164539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion.
ZA891583B (en) Piperazine derivative or its salt,process for producing the same and pharmaceutical composition comprising the same as active ingredient
IL86116A0 (en) Pharmaceutical compositions for the treatment of malaria
HUT50807A (en) Process for producing pharmaceutical compositions comprising labdane derivatives as active ingredient and for producing the active ingredient

Legal Events

Date Code Title Description
HS Change of address for service
KB Patent renewed
KB Patent renewed
KB Patent renewed